Cyclobenzaprine Hydrochloride
- Product NDC
- 60505-3972
- 11-digit product format
- 605053972
- Labeler code
- 60505
- Product ID
- 60505-3972_d5ad254d-7c8e-f25b-85d3-07dcbf61fac7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA206703
- Marketing category
- ANDA
- Marketing start
- 2019-03-01
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-3972-6 | 60505397206 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-3972-6) | 2019-03-01 | 0000-00-00 | No | No | Current |